Araştırma Makalesi

Quercetin versus folic acid: a comparative evaluation of protective effects on methotrexate-induced ovarian damage

Cilt: 7 Sayı: 1 31 Ocak 2026
PDF İndir
TR EN

Quercetin versus folic acid: a comparative evaluation of protective effects on methotrexate-induced ovarian damage

Öz

Background: Methotrexate (MTX) is a chemotherapeutic and immunosuppressive agent that acts as a folic acid reductase inhibitor and is widely used in various clinical settings. Despite its therapeutic efficacy, MTX has been shown in some experimental models to induce oxidative stress–mediated damage in ovarian tissue. This study aimed to evaluate and compare the protective effects of quercetin and folic acid against MTX-induced ovarian injury. Methods: Forty-two female Wistar albino rats were randomly divided into six groups (n=7): Control, QRC (quercetin), FA (folic acid), MTX (methotrexate), MTX+QRC (methotrexate+ folic acid), and MTX+FA (methotrexate+folic acid). Methotrexate was administered intraperitoneally at1mg/kg on days 1, 3, 5, and 7. quercetin(50mg/kg) and folic acid(20mg/kg) were administered orally on days 2, 4, 6, and 8. On day 9, ovarian tissues were collected for histopathological, immunohistochemical and biochemical analyses. Statistical analysis was conducted using one-way ANOVA and Kruskal-Wallis tests with Bonferroni and Dunn’s post hoc corrections (p<0.05). Results: Methotrexate significantly increased follicular degeneration, inflammation, vascular congestion, hemorrhage, edema, and fibrosis (p<0.001), as well as malondialdehyde (MDA) and pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) (p<0.001). It also significantly reduced anti-Mullerian hormone (AMH) levels, superoxide dismutase (SOD) and catalase (CAT) activities, and all follicle counts including primordial follicles (p<0.001). Both quercetin and folic acid treatments ameliorated these effects. Quercetin showed greater efficacy in reducing TNF-α and IL-1β levels (p<0.01) and restoring antioxidant enzyme activities(p<0.05), while folic acid was more effective in preserving AMH levels (p<0.01) and increasing primordial and Graafian follicle numbers (p<0.05). Conclusion: Although methotrexate remains an effective therapeutic agent, its ovarian toxicity poses a potential risk to long-term fertility. The present findings indicate that quercetin and folic acid exert protective effects against MTX-induced ovarian damage through distinct mechanisms: quercetin primarily by attenuating oxidative stress and inflammation, and folic acid by supporting folliculogenesis and preserving ovarian reserve.

Anahtar Kelimeler

Ovarian reserve, reproductive toxicology, methotrexate, quercetin, folic acid.

Destekleyen Kurum

This research received no external funding.

Etik Beyan

The rats were obtained and accommodated at the Experimental and Clinical Research Center of Erciyes University. The study was designed and conducted in compliance with the ARRIVE guidelines for in vivo animal research. Erciyes University Animal Experiments Local Ethics Committee approved our experimental guidelines (decision no: 22/174 date: 08.08.2022).

Kaynakça

  1. ACOG Practice Bulletin No. 193: Tubal Ectopic Pregnancy. Obstet Gynecol. 2018;131(3):613-615. doi:10.1097/AOG.0000000000002559.
  2. Orazulike NC, Konje JC. Diagnosis and management of ectopic pregnancy. Womens Health (Lond). 2013;9(4):373–385. doi:10.2217/whe.13.35.
  3. Stabile G, Romano F, Buonomo F, Zinicola G, Ricci G. Conservative treatment of interstitial ectopic pregnancy with the combination of mifepristone and methotrexate: our experience and review of the literature. Biomed Res Int. 2020;2020:8703496. doi:10.1155/2020/8703496.
  4. Tonick S, Conageski C. Ectopic pregnancy. Obstet Gynecol Clin North Am. 2022;49(3):537–549. doi:10.1016/j.ogc.2022.02.018.
  5. Kamel MY, Ahmed SM, Abdelzaher WY, Welson NN, Abdel Aziz AM. Role of IL-6/STAT3 pathway in mediating the protective effect of agomelatine against methotrexate-induced lung and intestinal tissue damage in rats. Immunopharmacol Immunotoxicol. 2022;44(1):35–46. doi:10.1080/08923973.2021.1999973.
  6. Kiremitli T, Kiremitli S, Akselim B, et al. Protective effect of coenzyme Q10 on oxidative ovarian and uterine damage induced by methotrexate in rats. Hum Exp Toxicol. 2021;40(9):1537-1544. doi:10.1177/09603271211002891.
  7. Carrillo Martinez EJ, Flores Hernández FY, Salazar Montes AM, Nario Chaidez HF, Hernández Ortega LD. Quercetin, a flavonoid with great pharmacological capacity. Molecules. 2024;29(3):1000. doi:10.3390/molecules29031000.
  8. Chen Z, Yuan Q, Xu G, et al. Effects of quercetin on proliferation and H2O2-induced apoptosis of intestinal porcine enterocyte cells. Molecules. 2018;23(8):2012. doi:10.3390/molecules23082012.
  9. Aldemir M, Özgün G, Önen E, Okulu EM, Kayıgil Ö. Quercetin has a protective role on histopathological findings in testicular ischaemia–reperfusion injury in rats. Andrologia. 2012;44(Suppl 1):479–483. doi:10.1111/j.1439-0272.2011.01210.x.
  10. Wang J, Zhu H, Wang K, Yang Z, Liu Z. Protective effect of quercetin on rat testes against cadmium toxicity by alleviating oxidative stress and autophagy. Environ Sci Pollut Res Int. 2020;27(24):25278–25286. doi:10.1007/s11356-020-09029-4.

Kaynak Göster

APA
Tozak Yıldız, H., Kalkan, K. T., Göktepe, Ö., Cengiz Mat, O., & Yay, A. (2026). Quercetin versus folic acid: a comparative evaluation of protective effects on methotrexate-induced ovarian damage. Archives of Current Medical Research, 7(1), 232-243. https://doi.org/10.47482/acmr.1729326
AMA
1.Tozak Yıldız H, Kalkan KT, Göktepe Ö, Cengiz Mat O, Yay A. Quercetin versus folic acid: a comparative evaluation of protective effects on methotrexate-induced ovarian damage. Arch Curr Med Res. 2026;7(1):232-243. doi:10.47482/acmr.1729326
Chicago
Tozak Yıldız, Halime, Kübra Tuğçe Kalkan, Özge Göktepe, Ozge Cengiz Mat, ve Arzu Yay. 2026. “Quercetin versus folic acid: a comparative evaluation of protective effects on methotrexate-induced ovarian damage”. Archives of Current Medical Research 7 (1): 232-43. https://doi.org/10.47482/acmr.1729326.
EndNote
Tozak Yıldız H, Kalkan KT, Göktepe Ö, Cengiz Mat O, Yay A (01 Ocak 2026) Quercetin versus folic acid: a comparative evaluation of protective effects on methotrexate-induced ovarian damage. Archives of Current Medical Research 7 1 232–243.
IEEE
[1]H. Tozak Yıldız, K. T. Kalkan, Ö. Göktepe, O. Cengiz Mat, ve A. Yay, “Quercetin versus folic acid: a comparative evaluation of protective effects on methotrexate-induced ovarian damage”, Arch Curr Med Res, c. 7, sy 1, ss. 232–243, Oca. 2026, doi: 10.47482/acmr.1729326.
ISNAD
Tozak Yıldız, Halime - Kalkan, Kübra Tuğçe - Göktepe, Özge - Cengiz Mat, Ozge - Yay, Arzu. “Quercetin versus folic acid: a comparative evaluation of protective effects on methotrexate-induced ovarian damage”. Archives of Current Medical Research 7/1 (01 Ocak 2026): 232-243. https://doi.org/10.47482/acmr.1729326.
JAMA
1.Tozak Yıldız H, Kalkan KT, Göktepe Ö, Cengiz Mat O, Yay A. Quercetin versus folic acid: a comparative evaluation of protective effects on methotrexate-induced ovarian damage. Arch Curr Med Res. 2026;7:232–243.
MLA
Tozak Yıldız, Halime, vd. “Quercetin versus folic acid: a comparative evaluation of protective effects on methotrexate-induced ovarian damage”. Archives of Current Medical Research, c. 7, sy 1, Ocak 2026, ss. 232-43, doi:10.47482/acmr.1729326.
Vancouver
1.Halime Tozak Yıldız, Kübra Tuğçe Kalkan, Özge Göktepe, Ozge Cengiz Mat, Arzu Yay. Quercetin versus folic acid: a comparative evaluation of protective effects on methotrexate-induced ovarian damage. Arch Curr Med Res. 01 Ocak 2026;7(1):232-43. doi:10.47482/acmr.1729326